EFFICACY AND SAFETY OF CHEMO-IMMUNOTHERAPY IN RECURRENT/METASTATIC HNSCC: A RETROSPECTIVE ANALYSIS

被引:0
|
作者
Salvestrini, Viola [1 ]
Frosini, Giulio [1 ]
Desideri, Isacco [1 ]
Becherini, Carlotta [1 ]
Angelini, Lucia [1 ]
Bonomo, Pierluigi [1 ]
Livi, Lorenzo [1 ]
机构
[1] Univ Florence, Radiat Oncol Unit, Azienda Osped Univ Careggi, Florence, Italy
关键词
Immunotherapy; recurrent and metastatic HNSCC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
144
引用
收藏
页码:S167 / S168
页数:3
相关论文
共 50 条
  • [31] Second line advanced or metastatic non-small cell lung cancer treatment after chemo-immunotherapy: a retrospective study
    Bazhenova, Lyudmila
    Cai, Beilei
    Gentile, Danielle
    Kish, Jonathan
    Feinberg, Bruce
    FUTURE ONCOLOGY, 2025,
  • [32] Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study
    Li, Guiling
    Cheng, Mingxia
    Hong, Kai
    Jiang, Yao
    ONCOTARGETS AND THERAPY, 2023, 16 : 157 - 163
  • [33] An increase in eosinophils is associate with response to chemo-immunotherapy in metastatic triple negative breast cancer
    Ghebeh, Hazem
    Elshenawy, Mahmoud A.
    Al-Sayed, Adher
    Al-Tweigeri, Taher
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [34] Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy -: A pilot study
    Kröger, MJ
    Menzel, TH
    Gschwend, JE
    Bergmann, L
    ANTICANCER RESEARCH, 1999, 19 (2C) : 1553 - 1556
  • [35] Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem
    Zhou, Feifan
    Wang, Meng
    Luo, Teng
    Qu, Junle
    Chen, Wei R.
    BIOMATERIALS, 2021, 265
  • [36] Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma
    Recchia, Francesco
    Saggio, Gaetano
    Amiconi, Giovanna
    Di Blasio, Anna
    Cesta, Alisia
    Candeloro, Giampiero
    Necozione, Stefano
    Fumagalli, Luca
    Rea, Silvio
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (04) : 448 - 454
  • [37] Toxicity spectrum and risk factors for chemo-immunotherapy in locally advanced or metastatic lung cancer
    Li, Jinjin
    Shi, Wenhao
    Xiong, Jin
    Huang, Yusheng
    He, Yi
    Zhou, Yan
    Yang, Zhenzhou
    Peng, Yuan
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 214 (02): : 162 - 169
  • [38] Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem
    Zhou, Feifan
    Wang, Meng
    Luo, Teng
    Qu, Junle
    Chen, Wei R.
    Biomaterials, 2021, 265
  • [39] CHEMO-IMMUNOTHERAPY WITH LEVAMISOLE IN METASTATIC BREAST-CARCINOMA - A CONTROLLED CLINICAL-TRIAL
    PATERSON, AHG
    NUTTING, M
    TAKATS, L
    EDWARDS, AM
    SCHINNOUR, D
    MCCLELLAND, A
    CANCER CLINICAL TRIALS, 1980, 3 (01) : 5 - 10
  • [40] High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
    Grambozov, Brane
    Stana, Markus
    Kaiser, Bernhard
    Karner, Josef
    Gerum, Sabine
    Ruznic, Elvis
    Zellinger, Barbara
    Moosbrugger, Raphaela
    Studnicka, Michael
    Fastner, Gerd
    Sedlmayer, Felix
    Zehentmayr, Franz
    CANCERS, 2022, 14 (03)